To provide access to quality addiction treatment anytime, anywhere!
AMCOT is committed to improve patient outcomes resulting from the devastating effects of addiction. This will be accomplished by expanding availability using innovative technologies like telemedicine and facilitating the provision of evidence-based addiction treatment and medication-assisted therapy in the state of Texas to include underserved areas.
To be recognized as the best addiction medicine specialty group for combating the opioid epidemic in underserved areas of Texas.
Services We Provide
Addiction Medicine Consultants of Texas (AMCOT) has opened an office in South Austin. AMCOT provides personalized, non-disciplinary treatment of addiction.
• medication-assisted treatment (MAT) for opioid and alcohol use disorders
• buprenorphine maintenance and tapers
• outpatient referral assistance
• professional monitoring and drug testing programs
• diagnosis and treatment of co-occurring mood disorders
Institutional Care (Onsite and Telemedicine)
• addiction medicine directorships for residential and IOP programs
• addiction medicine consults (AMC) in emergency room settings
• medication-assisted treatment (MAT) consults for facilities located anywhere in Texas
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment (MAT) is the use of medications, in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to the treatment of substance use disorders. Research shows that a combination of medication and therapy can successfully treat these disorders, and for some people struggling with addiction, MAT can help sustain recovery.
The Goal of MAT
The ultimate goal of MAT is full recovery, including the ability to live a self-directed life. This treatment approach has been shown to:
• improve patient survival
• increase retention in treatment
• decrease illicit opiate use and other criminal activity among people with substance use disorders
• increase patients’ ability to gain and maintain employment
• improve birth outcomes among women who have substance use disorders and are pregnant